What Researchers Did
Researchers treated three patients with sudden sensorineural hearing loss using intratympanic dexamethasone palmitate combined with HBOT, reporting outcomes in a small case series.
What They Found
All three patients showed hearing improvement following the combined treatment. The intratympanic route was well tolerated and may have enhanced local drug delivery compared to systemic steroids alone.
What This Means for Canadian Patients
Sudden hearing loss is a time-sensitive condition where combination therapies may improve recovery. Canadian patients presenting with sudden sensorineural hearing loss may benefit from early referral to facilities offering both intratympanic steroid and HBOT treatment.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Three patients is too small a sample to draw conclusions about efficacy or optimal treatment protocols.